Broadcom: Moving Big Into Vendor Financing

Broadcom (AVGO) shares are down 28% from June 2026 highs amid limited upward guidance and competitive pressure. Management projects $56B of FY26 and $100B+ of FY27 AI chip sales, with AI now contributing over half of segment revenue, but off-balance-sheet SPV financing tied to lessees like Anthropic introduces credit risk—reflected in spiking credit default swaps. Net: upbeat AI demand outlook is offset by guidance/competition concerns and measurable financing tail risk.

Analysis

The market is no longer treating AVGO as a pure semiconductor compounder; it is starting to reprice it as a hybrid of AI exposure plus embedded credit risk. That matters because once equity investors believe a slice of growth is being financed through off-balance-sheet structures, the multiple can compress faster than fundamentals deteriorate, especially if management is not re-accelerating forward guidance. In that regime, the stock can underperform even if unit demand remains healthy, because the debate shifts from TAM to quality of revenue and cash conversion.

Second-order, this creates a winner/loser split across the AI supply chain. Pure-play infrastructure names with cleaner balance sheets and less customer-financing complexity should get a relative bid, while vendors with similar financing optics or heavier customer concentration can face a tougher read-through. If hyperscalers conclude that custom silicon economics are becoming less transparent, they may diversify toward merchant GPUs, networking, or multi-vendor sourcing, which is a relative positive for NVDA, ANET, and potentially some mix-and-match spend across the ecosystem.

The near-term catalyst path is dominated by credit-market validation rather than product chatter. If CDS keeps widening or any customer funding stress becomes visible, the equity can gap lower again over days to weeks; over 1-3 months, the key check is whether management can restore upward guidance and separate operating demand from SPV economics. Over 6-18 months, the structural risk is that AVGO’s AI franchise is valued less like secular growth and more like leveraged finance with a chip wrapper, which would permanently lower the deserved multiple.

Contrarian view: the selloff may already reflect the easiest bearish argument, and the real question is whether the market is overestimating contagion from a small set of financed counterparties. If the SPV exposure is structurally ring-fenced and large customers keep spending, this becomes a sentiment overhang rather than an earnings impairment. What would falsify the bear case is a clean disclosure on lease/default exposure plus another meaningful upward revision in FY26/FY27 AI revenue; absent that, rallies look sellable.

Key Decisions for Investors

• Short AVGO on strength over the next 1-4 weeks; use any 5-10% rebound as entry, with a thesis stop if management provides explicit SPV transparency and tighter forward guidance that restores investor confidence.
• Pair trade: short AVGO / long ANET for 1-3 months to isolate financing and balance-sheet optics versus cleaner AI infrastructure exposure; risk is that AI capex softens broadly and takes both legs down.
• Buy AVGO downside via put spreads into the next earnings/guidance window if implied volatility is still below the historical stress level implied by widened CDS; target a 2:1 to 3:1 payoff if the market continues to punish financing risk.
• Set a watch item on AVGO credit spreads and any customer funding headlines; if CDS tightens materially and no new SPV issues emerge, cover part of the short as the market may be overpricing tail risk.